+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07291297

Metformin Hydrochloride with Standard First-Line Treatment for Advanced or Metastatic Soft Tissue Sarcoma A Phase II Study

Led by Wake Forest University Health Sciences · Updated on 2026-07-23

50

Participants Needed

2

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how metformin, combined with standard first-line systemic therapy, may affect outcomes in adults with advanced unresectable or metastatic soft tissue sarcoma. This single-arm, open-label phase II study aims to understand the potential benefits of adding metformin to physician-directed care for this condition. The study is sponsored by Wake Forest University Health Sciences and focuses on patients who have not yet been treated for advanced disease. Participants will start by taking 1000mg of extended-release metformin orally once daily for 14 days alongside standard care. If tolerated well without significant side effects or organ issues, the metformin dose may be increased to 1000mg twice daily starting on the fifteenth day of treatment. Treatment continues for up to five years or until early discontinuation, with careful monitoring of tolerance and safety throughout. During the study, participants will visit their healthcare provider to assess metformin toleration and receive systemic therapy. Researchers will track survival rates at 12 months as the primary outcome, along with overall survival and cancer-specific survival over approximately five years. The treatments safety and effectiveness will be monitored regularly through clinical visits and assessments during the long follow-up period.

CONDITIONS

Brief Title

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Research Team

L

Leah Wilson, RN

M

Megan Jagosky, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here